{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:39:05Z","timestamp":1792611545302,"version":"4.5.0"},"reference-count":43,"publisher":"MyJove Corporation","issue":"192","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/64858","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T19:01:54Z","timestamp":1676055714000},"source":"Crossref","is-referenced-by-count":11,"title":["Gene Editing of Primary Rhesus Macaque B Cells"],"prefix":"10.3791","author":[{"given":"Harald","family":"Hartweger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Gautam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Hui","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Escolano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mila","family":"Jankovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm A.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel C.","family":"Nussenzweig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2023,2,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","type":"journal-article","article-title":"Germinal centers","volume":"40","author":"Victora","year":"2022","unstructured":"Victora, G. D., Nussenzweig, M. C. Germinal centers. Annual Review of Immunology. 40, 413-442 (2022).","journal-title":"Annual Review of Immunology"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","type":"journal-article","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","unstructured":"Plotkin, S. A. Correlates of protection induced by vaccination. Clinical and Vaccine Immunology. 17 (7), 1055-1065 (2010).","journal-title":"Clinical and Vaccine Immunology"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/cimm.1993.1294","type":"journal-article","article-title":"T cell-dependent differentiation of human B cells into IgM, IgG, IgA, or IgE plasma cells: High rate of antibody production by IgE plasma cells, but limited clonal expansion of IgE precursors","volume":"152","author":"Brinkmann","year":"1993","unstructured":"Brinkmann, V., Heusser, C. H. T cell-dependent differentiation of human B cells into IgM, IgG, IgA, or IgE plasma cells: High rate of antibody production by IgE plasma cells, but limited clonal expansion of IgE precursors. Cellular Immunology. 152 (2), 323-332 (1993).","journal-title":"Cellular Immunology"},{"key":"ref4","type":"book","volume-title":"Protein Electrophoresis - Serum., 6th edition","author":"Chernecky","year":"2013","unstructured":"Chernecky, C. C., Berger, B. J. Protein Electrophoresis - Serum., 6th edition, 917-920. Elsevier Saunders. St Louis, MO. (2013)."},{"issue":"7379","key":"ref5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nature10660","type":"journal-article","article-title":"Antibody-based protection against HIV infection by vectored immunoprophylaxis","volume":"481","author":"Balazs","year":"2011","unstructured":"Balazs, A. B. et al. Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature. 481 (7379), 81-84 (2011).","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.isci.2019.01.032","type":"journal-article","article-title":"CRISPR-mediated editing of the B cell receptor in primary human B cells","volume":"12","author":"Greiner","year":"2019","unstructured":"Greiner, V. et al. CRISPR-mediated editing of the B cell receptor in primary human B cells. iScience. 12, 369-378 (2019).","journal-title":"iScience"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1084\/jem.20190287","type":"journal-article","article-title":"HIV-specific humoral immune responses by CRISPR\/Cas9-edited B cells","volume":"216","author":"Hartweger","year":"2019","unstructured":"Hartweger, H. et al. HIV-specific humoral immune responses by CRISPR\/Cas9-edited B cells. Journal of Experimental Medicine. 216 (6), 1301-1310 (2019).","journal-title":"Journal of Experimental Medicine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1038\/s41467-020-19650-8","type":"journal-article","article-title":"Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells","volume":"11","author":"Huang","year":"2020","unstructured":"Huang, D. et al. Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells. Nature Communications. 11, 5850 (2020).","journal-title":"Nature Communications"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.4049\/jimmunol.2100340","type":"journal-article","article-title":"Vector strategies to actualize B cell-based gene therapies","volume":"207","author":"Jeske","year":"2021","unstructured":"Jeske, A. M., Boucher, P., Curiel, D. T., Voss, J. E. Vector strategies to actualize B cell-based gene therapies. Journal of Immunology. 207 (3), 755-764 (2021).","journal-title":"Journal of Immunology"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/s41587-022-01328-9","type":"journal-article","article-title":"In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice","volume":"40","author":"Nahmad","year":"2022","unstructured":"Nahmad, A. D. et al. In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice. Nature Biotechnology. 40 (8), 1241-1249 (2022).","journal-title":"Nature Biotechnology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1038\/s41467-020-19649-1","type":"journal-article","article-title":"Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion","volume":"11","author":"Nahmad","year":"2020","unstructured":"Nahmad, A. D. et al. Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion. Nature Communications. 11, 5851 (2020).","journal-title":"Nature Communications"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"42995","DOI":"10.7554\/eLife.42995","type":"journal-article","article-title":"Reprogramming the antigen specificity of B cells using genome-editing technologies","volume":"8","author":"Voss","year":"2019","unstructured":"Voss, J. E. et al. Reprogramming the antigen specificity of B cells using genome-editing technologies. eLife. 8, e42995 (2019).","journal-title":"eLife"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.3389\/fimmu.2019.02630","type":"journal-article","article-title":"Molecular design, optimization, and genomic integration of chimeric B cell receptors in murine B cells","volume":"10","author":"Pesch","year":"2019","unstructured":"Pesch, T. et al. Molecular design, optimization, and genomic integration of chimeric B cell receptors in murine B cells. Frontiers in Immunology. 10, 2630 (2019).","journal-title":"Frontiers in Immunology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"10934","DOI":"10.1038\/ncomms10934","type":"journal-article","article-title":"Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system","volume":"7","author":"Cheong","year":"2016","unstructured":"Cheong, T. C., Compagno, M., Chiarle, R. Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system. Nature Communications. 7, 10934 (2016).","journal-title":"Nature Communications"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1016\/j.ymthe.2021.09.019","type":"journal-article","article-title":"Genome edited B cells: A new frontier in immune cell therapies","volume":"29","author":"Rogers","year":"2021","unstructured":"Rogers, G. L., Cannon, P. M. Genome edited B cells: A new frontier in immune cell therapies. Molecular Therapy. 29 (11), 3192-3204 (2021).","journal-title":"Molecular Therapy"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymthe.2017.11.012","type":"journal-article","article-title":"Engineering protein-secreting plasma cells by homology-directed repair in primary human B cells","volume":"26","author":"Hung","year":"2018","unstructured":"Hung, K. L. et al. Engineering protein-secreting plasma cells by homology-directed repair in primary human B cells. Molecular Therapy. 26 (2), 456-467 (2018).","journal-title":"Molecular Therapy"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"12144","DOI":"10.1038\/s41598-018-30358-0","type":"journal-article","article-title":"Engineering of primary human B cells with CRISPR\/Cas9 targeted nuclease","volume":"8","author":"Johnson","year":"2018","unstructured":"Johnson, M. J., Laoharawee, K., Lahr, W. S., Webber, B. R., Moriarity, B. S. Engineering of primary human B cells with CRISPR\/Cas9 targeted nuclease. Scientific Reports. 8, 12144 (2018).","journal-title":"Scientific Reports"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jim.2018.03.009","type":"journal-article","article-title":"Genetic engineering in primary human B cells with CRISPR-Cas9 ribonucleoproteins","volume":"457","author":"Wu","year":"2018","unstructured":"Wu, C. M. et al. Genetic engineering in primary human B cells with CRISPR-Cas9 ribonucleoproteins. Journal of Immunological Methods. 457, 33-40 (2018).","journal-title":"Journal of Immunological Methods"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41419-020-03187-1","type":"journal-article","article-title":"Engineering of alpha-PD-1 antibody-expressing long-lived plasma cells by CRISPR\/Cas9-mediated targeted gene integration","volume":"11","author":"Luo","year":"2020","unstructured":"Luo, B. et al. Engineering of alpha-PD-1 antibody-expressing long-lived plasma cells by CRISPR\/Cas9-mediated targeted gene integration. Cell Death and Disease. 11 (11), 973 (2020).","journal-title":"Cell Death and Disease"},{"issue":"165","key":"ref20","first-page":"e61855","type":"journal-article","article-title":"Genome engineering of primary human B cells using CRISPR\/Cas9","author":"Laoharawee","year":"2020","unstructured":"Laoharawee, K. et al. Genome engineering of primary human B cells using CRISPR\/Cas9. Journal of Visualized Experiments. (165), e61855 (2020).","journal-title":"Journal of Visualized Experiments"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/978-1-0716-0290-4_24","type":"journal-article","article-title":"CRISPR\/Cas9-mediated genome engineering of primary human B cells","volume":"2115","author":"Laoharawee","year":"2020","unstructured":"Laoharawee, K., Johnson, M. J., Moriarity, B. S. CRISPR\/Cas9-mediated genome engineering of primary human B cells. Methods in Molecular Biology. 2115, 435-444 (2020).","journal-title":"Methods in Molecular Biology"},{"issue":"35","key":"ref22","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aax0644","type":"journal-article","article-title":"B cells engineered to express pathogen-specific antibodies protect against infection","volume":"4","author":"Moffett","year":"2019","unstructured":"Moffett, H. F. et al. B cells engineered to express pathogen-specific antibodies protect against infection. Science Immunology. 4 (35), eaax0644 (2019).","journal-title":"Science Immunology"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41587-022-01299-x","type":"journal-article","article-title":"CRISPR comes a-knock-in to reprogram antibodies in vivo","volume":"40","author":"Hartweger","year":"2022","unstructured":"Hartweger, H., Nussenzweig, M. C. CRISPR comes a-knock-in to reprogram antibodies in vivo. Nature Biotechnology. 40 (8), 1183-1184 (2022).","journal-title":"Nature Biotechnology"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.chom.2017.07.010","type":"journal-article","article-title":"Of mice, macaques, and men: Broadly neutralizing antibody immunotherapy for HIV-1","volume":"22","author":"Nishimura","year":"2017","unstructured":"Nishimura, Y., Martin, M. A. Of mice, macaques, and men: Broadly neutralizing antibody immunotherapy for HIV-1. Cell Host & Microbe. 22 (2), 207-216 (2017).","journal-title":"Cell Host & Microbe"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nri2636","type":"journal-article","article-title":"Monkeying around with HIV vaccines: Using rhesus macaques to define 'gatekeepers' for clinical trials","volume":"9","author":"Shedlock","year":"2009","unstructured":"Shedlock, D. J., Silvestri, G., Weiner, D. B. Monkeying around with HIV vaccines: Using rhesus macaques to define 'gatekeepers' for clinical trials. Nature Reviews Immunology. 9 (10), 717-728 (2009).","journal-title":"Nature Reviews Immunology"},{"key":"ref26","type":"journal-article","article-title":"Efficient methods for generation and expansion of, and gene delivery to rhesus macaque plasma B cells","author":"Kreuser","year":"2021","unstructured":"Kreuser, S. et al. Efficient methods for generation and expansion of, and gene delivery to rhesus macaque plasma B cells. bioRxiv. (2021).","journal-title":"bioRxiv"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2567.2011.03484.x","type":"journal-article","article-title":"Human and rhesus plasmacytoid dendritic cell and B-cell responses to Toll-like receptor stimulation","volume":"134","author":"Gujer","year":"2011","unstructured":"Gujer, C., Sundling, C., Seder, R. A., Karlsson Hedestam, G. B., Lore, K. Human and rhesus plasmacytoid dendritic cell and B-cell responses to Toll-like receptor stimulation. Immunology. 134 (3), 257-269 (2011).","journal-title":"Immunology"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbrc.2016.03.057","type":"journal-article","article-title":"Cell enrichment-free massive ex-vivo expansion of peripheral CD20(+) B cells via CD40-CD40L signals in non-human primates","volume":"473","author":"Kim","year":"2016","unstructured":"Kim, J. S. et al. Cell enrichment-free massive ex-vivo expansion of peripheral CD20(+) B cells via CD40-CD40L signals in non-human primates. Biochemical and Biophysical Research Communications. 473 (1), 92-98 (2016).","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/s41467-022-28738-2","type":"journal-article","article-title":"Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination","volume":"13","author":"Su","year":"2022","unstructured":"Su, W. et al. Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination. Nature Communications. 13, 1182 (2022).","journal-title":"Nature Communications"},{"issue":"15","key":"ref30","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.1128\/JVI.74.15.6935-6945.2000","type":"journal-article","article-title":"Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian\/human immunodeficiency virus","volume":"74","author":"Endo","year":"2000","unstructured":"Endo, Y. et al. Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian\/human immunodeficiency virus. Journal of Virology. 74 (15), 6935-6945 (2000).","journal-title":"Journal of Virology"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1007\/s00464-015-4118-9","type":"journal-article","article-title":"Partial splenectomy in the era of minimally invasive surgery: The current laparoscopic and robotic experiences","volume":"29","author":"Balaphas","year":"2015","unstructured":"Balaphas, A., Buchs, N. C., Meyer, J., Hagen, M. E., Morel, P. Partial splenectomy in the era of minimally invasive surgery: The current laparoscopic and robotic experiences. Surgical Endoscopy. 29 (12), 3618-3627 (2015).","journal-title":"Surgical Endoscopy"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nmeth.1318","type":"journal-article","article-title":"Enzymatic assembly of DNA molecules up to several hundred kilobases","volume":"6","author":"Gibson","year":"2009","unstructured":"Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nature Methods. 6 (5), 343-345 (2009).","journal-title":"Nature Methods"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/nar\/gkz365","type":"journal-article","article-title":"CHOPCHOP v3: Expanding the CRISPR web toolbox beyond genome editing","volume":"47","author":"Labun","year":"2019","unstructured":"Labun, K. et al. CHOPCHOP v3: Expanding the CRISPR web toolbox beyond genome editing. Nucleic Acids Research. 47 (W1), W171-W174 (2019).","journal-title":"Nucleic Acids Research"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/hgtb.2015.051","type":"journal-article","article-title":"Comparative analysis of cesium chloride- and iodixanol-based purification of recombinant adeno-associated viral vectors for preclinical applications","volume":"26","author":"Strobel","year":"2015","unstructured":"Strobel, B., Miller, F. D., Rist, W., Lamla, T. Comparative analysis of cesium chloride- and iodixanol-based purification of recombinant adeno-associated viral vectors for preclinical applications. Human Gene Therapy Methods. 26 (4), 147-157 (2015).","journal-title":"Human Gene Therapy Methods"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jviromet.2012.04.004","type":"journal-article","article-title":"Rapid and simplified purification of recombinant adeno-associated virus","volume":"183","author":"Guo","year":"2012","unstructured":"Guo, P. et al. Rapid and simplified purification of recombinant adeno-associated virus. Journal of Virological Methods. 183 (2), 139-146 (2012).","journal-title":"Journal of Virological Methods"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1089\/hum.2010.107","type":"journal-article","article-title":"Efficient serotype-dependent release of functional vector into the culture medium during adeno-associated virus manufacturing","volume":"21","author":"Vandenberghe","year":"2010","unstructured":"Vandenberghe, L. H. et al. Efficient serotype-dependent release of functional vector into the culture medium during adeno-associated virus manufacturing. Human Gene Therapy. 21 (10), 1251-1257 (2010).","journal-title":"Human Gene Therapy"},{"issue":"22","key":"ref37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/nar\/gku936","type":"journal-article","article-title":"Easy quantitative assessment of genome editing by sequence trace decomposition","volume":"42","author":"Brinkman","year":"2014","unstructured":"Brinkman, E. K., Chen, T., Amendola, M., van Steensel, B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Research. 42 (22), e168 (2014).","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/crispr.2021.0113","type":"journal-article","article-title":"Inference of CRISPR edits from Sanger trace data","volume":"5","author":"Conant","year":"2022","unstructured":"Conant, D. et al. Inference of CRISPR edits from Sanger trace data. The CRISPR Journal. 5 (1), 123-130 (2022).","journal-title":"The CRISPR Journal"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41467-021-20909-x","type":"journal-article","article-title":"Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice","volume":"12","author":"Wilkinson","year":"2021","unstructured":"Wilkinson, A. C. et al. Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice. Nature Communications. 12, 686 (2021).","journal-title":"Nature Communications"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"61991","DOI":"10.7554\/eLife.61991","type":"journal-article","article-title":"A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patch","volume":"9","author":"Wang","year":"2020","unstructured":"Wang, Z. et al. A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patch. eLife. 9, e61991 (2020).","journal-title":"eLife"},{"issue":"7762","key":"ref41","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41586-019-1250-z","type":"journal-article","article-title":"Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques","volume":"570","author":"Escolano","year":"2019","unstructured":"Escolano, A. et al. Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature. 570 (7762), 468-473 (2019).","journal-title":"Nature"},{"issue":"1","key":"ref42","first-page":"70","type":"journal-article","article-title":"Leukapheresis protocol for nonhuman primates weighing less than 10 kg","volume":"52","author":"Pathiraja","year":"2013","unstructured":"Pathiraja, V., Matar, A. J., Gusha, A., Huang, C. A., Duran-Struuck, R. Leukapheresis protocol for nonhuman primates weighing less than 10 kg. Journal of the American Association for Laboratory Animal Science. 52 (1), 70-77 (2013).","journal-title":"Journal of the American Association for Laboratory Animal Science"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"0198637","DOI":"10.1371\/journal.pone.0198637","type":"journal-article","article-title":"DMSO increases efficiency of genome editing at two non-coding loci","volume":"13","author":"Stratigopoulos","year":"2018","unstructured":"Stratigopoulos, G., De Rosa, M. C., LeDuc, C. A., Leibel, R. L., Doege, C. A. DMSO increases efficiency of genome editing at two non-coding loci. PLoS One. 13 (6), e0198637 (2018).","journal-title":"PLoS One"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/64858\/gene-editing-of-primary-rhesus-macaque-b-cells","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:50:26Z","timestamp":1792608626000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/64858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":43,"journal-issue":{"issue":"192","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.3791\/64858","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,10]]}}}